Aptevo Therapeutics, Inc. (APVO)
9.43
+0.04
(+0.43%)
USD |
NASDAQ |
Dec 31, 16:00
9.445
+0.02
(+0.16%)
After-Hours: 20:00
Aptevo Therapeutics EPS Diluted (Quarterly): -40.13 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| Dermata Therapeutics, Inc. | -1.648 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.028M |
| Total Expenses (Quarterly) | 9.028M |
| Enterprise Value | -15.38M |
| Earnings Yield | -35.33K% |
| Normalized Earnings Yield | -35325.46 |